Insights On Liquid Dose Manufacturing

  1. Consistent, Reliable, High-Quality Components 2/3/2026

    Discover a premium line of components for vials, prefilled syringes, and cartridge systems developed and refined to provide best-in-class levels of quality, performance, and risk mitigation.

  2. Identifying Worst-Case Locations Assessing Homogeneity Using BIs And EIs 7/27/2026

    Combine quantitative enzyme indicators, computational fluid dynamics, and traditional biological indicators to improve VPHP isolator validation and process confidence.

  3. Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know 5/14/2026

    Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

  4. Navigating Sterile Injectable CMO Selection: A Technical And Quality Assessment 6/11/2025

    Learn how to carry out an effective technical and quality assessment and what specific criteria to prioritize when selecting a sterile injectable CMO partner.

  5. Why Choose Robotic Processing For Small Batch Aseptic Filling 1/9/2026

    Reducing human intervention in aseptic filling is critical for safety and cost efficiency. Learn why automation is essential for small-batch applications and how it’s transforming sterile drug manufacturing.

  6. Simulating PUPSIT Or Gas Purges In Bacterial Challenge Tests 5/22/2026

    Managing PUPSIT‑related risks is a critical part of contamination control. Learn how bacterial retention studies, wetting fluids, and downstream practices influence sterility assurance.

  7. Service Solutions Designed To Help You Gain Speed To Clinic And Market 4/28/2025

    Discover how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.

  8. Spray Dried Biologics For Injectable Dosage Forms 5/15/2026

    Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

  9. De-Risking The Transition From Vial To Drug-Device Combination Product 7/25/2025

    When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

  10. From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System 6/2/2026

    Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.